Takano S - Search Results

1

Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors.

Takano S, Kato Y, Yamamoto T, Kaneko MK, Ishikawa E, Tsujimoto Y, Matsuda M, Nakai K, Yanagiya R, Morita S, Tsuboi K, Matsumura A. Takano S, et al. J Neurooncol. 2012 Jul;108(3):361-73. doi: 10.1007/s11060-012-0837-0. Epub 2012 Mar 7. J Neurooncol. 2012. PMID: 22396072

2

Cervical intramedullary gliofibroma in a child: a case report and review of the literature.

Matsumura A, Takano S, Nagata M, Anno I, Nose T. Matsumura A, et al. Among authors: takano s. Pediatr Neurosurg. 2002 Feb;36(2):105-10. doi: 10.1159/000048362. Pediatr Neurosurg. 2002. PMID: 11893894

3

Anti-vascular endothelial growth factor antibody and nimustine as combined therapy: effects on tumour growth and angiogenesis in human glioblastoma xenografts.

Takano S, Tsuboi K, Matsumura A, Nose T. Takano S, et al. Neuro Oncol. 2003 Jan;5(1):1-7. doi: 10.1093/neuonc/5.1.1. Neuro Oncol. 2003. PMID: 12626127 Free PMC article.

4

Effects of local injection of ex vivo expanded autologous tumor-specific T lymphocytes in cases with recurrent malignant gliomas.

Tsuboi K, Saijo K, Ishikawa E, Tsurushima H, Takano S, Morishita Y, Ohno T. Tsuboi K, et al. Among authors: takano s. Clin Cancer Res. 2003 Aug 15;9(9):3294-302. Clin Cancer Res. 2003. PMID: 12960115

5

Intratumoral injection of IL-2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor model.

Ishikawa E, Tsuboi K, Takano S, Uchimura E, Nose T, Ohno T. Ishikawa E, et al. Among authors: takano s. Cancer Sci. 2004 Jan;95(1):98-103. doi: 10.1111/j.1349-7006.2004.tb03177.x. Cancer Sci. 2004. PMID: 14720334 Free PMC article.

6

Autologous natural killer cell therapy for human recurrent malignant glioma.

Ishikawa E, Tsuboi K, Saijo K, Harada H, Takano S, Nose T, Ohno T. Ishikawa E, et al. Among authors: takano s. Anticancer Res. 2004 May-Jun;24(3b):1861-71. Anticancer Res. 2004. PMID: 15274367 Free article. Clinical Trial.

7

X-irradiation to human malignant glioma cells enhances the cytotoxicity of autologous killer lymphocytes under specific conditions.

Ishikawa E, Tsuboi K, Saijo K, Takano S, Ohno T. Ishikawa E, et al. Among authors: takano s. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1505-12. doi: 10.1016/j.ijrobp.2004.04.046. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275738

8

Clinical results of proton beam therapy for skull base chordoma.

Igaki H, Tokuuye K, Okumura T, Sugahara S, Kagei K, Hata M, Ohara K, Hashimoto T, Tsuboi K, Takano S, Matsumura A, Akine Y. Igaki H, et al. Among authors: takano s. Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1120-6. doi: 10.1016/j.ijrobp.2004.05.064. Int J Radiat Oncol Biol Phys. 2004. PMID: 15519783 Review.

9

Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1alpha)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cells.

Kamiyama H, Takano S, Tsuboi K, Matsumura A. Kamiyama H, et al. Among authors: takano s. J Cancer Res Clin Oncol. 2005 Apr;131(4):205-13. doi: 10.1007/s00432-004-0642-z. Epub 2004 Dec 4. J Cancer Res Clin Oncol. 2005. PMID: 15583935

10

Angiogenesis and antiangiogenic therapy for malignant gliomas.

Takano S, Kamiyama H, Tsuboi K, Matsumura A. Takano S, et al. Brain Tumor Pathol. 2004;21(2):69-73. doi: 10.1007/BF02484513. Brain Tumor Pathol. 2004. PMID: 15700836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,219 results

Search Page

Filters